0
Abstract: Case Reports |

Cryptococcal Laryngitis FREE TO VIEW

Hassan F. Nadrous, MD; Jay H. Ryu, MD; Jean Lewis, MD; Alain N. Sabri, MD.
Author and Funding Information

Mayo Clinic, Rochester, MN


Chest


Chest. 2003;124(4_MeetingAbstracts):307S-a-308S. doi:10.1378/chest.124.4_MeetingAbstracts.307S-a
Text Size: A A A
Published online

INTRODUCTION:  Cryptococcal infection range from asymptomatic pulmonary colonization to life-threatening meningitis.12. Laryngeal cryptococcal infections are exceedingly rare.

CASE PRESENTATION:  A 55-year-old man was evaluated for hoarseness and worsening cough of 6 weeks’ duration. His past medical history was notable for asthma, allergic fungal sinusitis, and sinus surgery. His medications included inhaled albuterol, and flunisolide. He also had stopped using fluticasone nasal spray recently. His physical examination was unremarkable, except for a patch of leukoplakia on the right anterior vocal cord with erythema of the entire right vocal cord noted on fiberoptic endoscopy. Biopsy of the right vocal cord lesion was performed. GMS stain of the biopsy specimen revealed the fungal organisms with morphologic features of Cryptococcus Neoformans and the fungal culture grew Cryptococcus Neoformans. Evaluation for cryptococcal dissemination was negative.Patient was treated by itraconazole 200 mg twice daily for 6 weeks followed by fluconazole 400 mg a day for 10 additional weeks. Patient was disease-free at the end of the treatment course and at 10-month follow-up visit.DISCUSSION: Our case represents the sixth case of laryngeal cryptococcal infection in the literature.The most common presenting symptom among these cases was hoarseness and only one patient required tracheostomy3. In general, antifungal therapy is recommended for most patients with cryptococcal infections, especially those patients who are immunocompromised.CONCLUSIONS: Cryptococcal laryngeal infection is rare but it should be considered in the differential diagnosis of persistent hoarseness occurring in an immunocompromised subject. Inhaled corticosteroid therapy may be a predisposing factor for cryptococcal laryngitis in non-immunocompromised subjects.

DISCLOSURE:  H.F. Nadrous, None.

Wednesday, October 29, 2003

2:00 PM - 3:30 PM

References

Levitz SM., The ecology of Cryptococcus neoformans and the epidemiology of cryptococcosis.Rev Infect Dis.1991;13:1163–1169. [CrossRef]
 
Rozenbaum R, Goncalves AJ., Clinical epidemiological study of 171 cases of cryptococcosis.Clin Infect Dis.1994;18:369–380. [CrossRef]
 
Isaacson JE, Frable MA., Cryptococcosis of the larynx.Otolaryngol Head Neck Surg.1996;114:106–109. [CrossRef]
 

Figures

Tables

References

Levitz SM., The ecology of Cryptococcus neoformans and the epidemiology of cryptococcosis.Rev Infect Dis.1991;13:1163–1169. [CrossRef]
 
Rozenbaum R, Goncalves AJ., Clinical epidemiological study of 171 cases of cryptococcosis.Clin Infect Dis.1994;18:369–380. [CrossRef]
 
Isaacson JE, Frable MA., Cryptococcosis of the larynx.Otolaryngol Head Neck Surg.1996;114:106–109. [CrossRef]
 
NOTE:
Citing articles are presented as examples only. In non-demo SCM6 implementation, integration with CrossRef’s "Cited By" API will populate this tab (http://www.crossref.org/citedby.html).

Some tools below are only available to our subscribers or users with an online account.

Related Content

Customize your page view by dragging & repositioning the boxes below.

Find Similar Articles
CHEST Journal Articles
PubMed Articles
  • CHEST Journal
    Print ISSN: 0012-3692
    Online ISSN: 1931-3543